MARKET

MBIO

MBIO

Mustang Bio
NASDAQ
0.7137
+0.0137
+1.96%
After Hours: 0.7295 +0.0158 +2.21% 16:11 04/13 EDT
OPEN
0.7000
PREV CLOSE
0.7000
HIGH
0.7500
LOW
0.6913
VOLUME
19.61K
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
0.5306
MARKET CAP
5.41M
P/E (TTM)
-1.8235
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MBIO last week (0406-0410)?
Weekly Report · 18h ago
Weekly Report: what happened at MBIO last week (0330-0403)?
Weekly Report · 04/06 09:32
Weekly Report: what happened at MBIO last week (0323-0327)?
Weekly Report · 03/30 09:32
Weekly Report: what happened at MBIO last week (0316-0320)?
Weekly Report · 03/23 09:31
Mustang Bio FY 2025 net loss narrows 88% to USD 1.92 million on R&D expense down 118% to USD -1.52 million
Reuters · 03/19 20:09
Weekly Report: what happened at MBIO last week (0309-0313)?
Weekly Report · 03/16 09:30
Weekly Report: what happened at MBIO last week (0302-0306)?
Weekly Report · 03/09 09:31
Weekly Report: what happened at MBIO last week (0223-0227)?
Weekly Report · 03/02 09:31
More
About MBIO
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs into potential cures for cancers and autoimmune diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR T) therapies. Its pipeline is focused in two core areas: CAR T therapies for autoimmune diseases and hematologic malignancies and CAR T therapies for solid tumors. It is developing a CAR T therapy for hematologic malignancies and autoimmune diseases in partnership with Fred Hutchinson Cancer Center targeting CD20 and for solid tumors in partnership with City of Hope National Medical Center targeting IL13Ra2. It has also partnered with Nationwide Children’s Hospital for a herpes simplex virus type 1 oncolytic virus to enhance the activity of MB-101 for the treatment of patients with high-grade malignant brain tumors.

Webull offers Mustang Bio Inc stock information, including NASDAQ: MBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBIO stock methods without spending real money on the virtual paper trading platform.